Memgen, LLC Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2004)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2006
NCT00850057
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Memgen, Inc.